BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26400478)

  • 1. [Fertility preservation in breast cancer patients by embryo cryopreservation after ovarian stimulation with letrozole and FSH].
    Beckmann MW; Findeklee S
    Strahlenther Onkol; 2015 Nov; 191(11):895-6. PubMed ID: 26400478
    [No Abstract]   [Full Text] [Related]  

  • 2. More Options for Fertility Preservation for Patients With Cancer.
    Munster PN
    J Clin Oncol; 2015 Aug; 33(22):2413-5. PubMed ID: 26101241
    [No Abstract]   [Full Text] [Related]  

  • 3. Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer.
    Oktay K; Turan V; Bedoschi G; Pacheco FS; Moy F
    J Clin Oncol; 2015 Aug; 33(22):2424-9. PubMed ID: 26101247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The case for aromatase inhibitors use in oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in breast cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate.
    Fatum M; McVeigh E; Child T
    Hum Fertil (Camb); 2013 Dec; 16(4):235-40. PubMed ID: 23863119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes.
    Turan V; Bedoschi G; Emirdar V; Moy F; Oktay K
    Reprod Sci; 2018 Jan; 25(1):26-32. PubMed ID: 28874104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients.
    Turan V; Bedoschi G; Moy F; Oktay K
    Fertil Steril; 2013 Dec; 100(6):1681-5.e1. PubMed ID: 24055050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles.
    Sönmezer M; Türkçüoğlu I; Coşkun U; Oktay K
    Fertil Steril; 2011 May; 95(6):2125.e9-11. PubMed ID: 21292255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
    Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
    Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
    Noriega-Portella L; Noriega-Hoces L; Delgado A; Rubio J; Gonzales-Castañeda C; Gonzales GF
    Fertil Steril; 2008 Nov; 90(5):1818-25. PubMed ID: 18083169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer?
    Lee S; Oktay K
    Fertil Steril; 2012 Oct; 98(4):961-4.e1. PubMed ID: 22771027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
    Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
    Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes†.
    Pereira N; Hancock K; Cordeiro CN; Lekovich JP; Schattman GL; Rosenwaks Z
    Gynecol Endocrinol; 2016 Oct; 32(10):823-826. PubMed ID: 27114051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone.
    Lee S; Ozkavukcu S; Heytens E; Moy F; Alappat RM; Oktay K
    J Assist Reprod Genet; 2011 Jul; 28(7):651-6. PubMed ID: 21573682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility preservation in women with breast cancer.
    Rodriguez-Wallberg KA; Oktay K
    Clin Obstet Gynecol; 2010 Dec; 53(4):753-62. PubMed ID: 21048442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twin delivery after IVF-ET with variable dose letrozole-FSH protocol of lower estradiol in a patient previously treated for breast cancer: a case report.
    Zhang CJ; Zhang Y; Hu GZ; Diao H
    Eur J Gynaecol Oncol; 2016; 37(2):278-81. PubMed ID: 27172763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial.
    Dahhan T; Balkenende EME; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; van Golde RJT; Schipper I; Louwé LA; Cantineau AEP; Smeenk JMJ; de Bruin JP; Reddy N; Kopeika Y; van der Veen F; van Wely M; Linn SC; Goddijn M
    Contemp Clin Trials; 2017 Oct; 61():96-100. PubMed ID: 28710053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial comparing superovulation with letrozole versus recombinant follicle-stimulating hormone combined with intrauterine insemination for couples with unexplained infertility who had failed clomiphene citrate stimulation and intrauterine insemination.
    Gregoriou O; Vlahos NF; Konidaris S; Papadias K; Botsis D; Creatsas GK
    Fertil Steril; 2008 Sep; 90(3):678-83. PubMed ID: 17961561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility preservation options in breast cancer patients.
    Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
    Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose administration of an aromatase inhibitor for ovarian stimulation.
    Mitwally MF; Casper RF
    Fertil Steril; 2005 Jan; 83(1):229-31. PubMed ID: 15652918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Random-start ovarian stimulation in patients with cancer.
    Cakmak H; Rosen MP
    Curr Opin Obstet Gynecol; 2015 Jun; 27(3):215-21. PubMed ID: 25919235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.